Publication date: July 2017
Source:Cancer Treatment Reviews, Volume 58
Author(s): Lu Zhang, Michele Ghielmini, Bruce D. Cheson, Chaitra Ujjani
Follicular lymphoma (FL) is the most prevalent indolent non-Hodgkin lymphoma. Most patients present with advanced disease and are incurable with current therapy. The approval of rituximab has revolutionized the treatment of follicular lymphoma when administered in the induction setting for high-tumor burden disease, but the use of rituximab as a maintenance therapy (MR) continues to be a point of controversy. In this article, we review the main data and arguments in favor and against MR in FL. In summary, most studies have demonstrated a significant benefit in progression-free or event-free survival in this notoriously recurrent disease; however, long-term outcomes could not consistently demonstrate to be improved with this intervention. In a meta-analysis of randomized trials overall survival (OS) showed a tendency to improvement when given to patients in relapse, but no single study reached a significant OS advantage. The risk of high-grade transformation does not seem to be reduced in prospective trials. On the other hand, MR clearly increases toxicity without an improvement in quality of life. Finally, MR is expensive, and it is not proven that the delayed relapse time can compensate for these costs. In conclusion, despite the proven increase in progression-free survival, MR can't be recommended as a standard for the treatment of FL.
http://ift.tt/2tEEt3b
http://ift.tt/2rIhB6s
Ιατρική : Τα αισθητικά συστήματα της όρασης,ακοής,αφής,γεύσης και όσφρησης.
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Behavioral dysfunctions (BPSD) represent the most important problem in Alzheimer's dementia (AD) management. We assessed the ...
-
REVIEW ARTICLE Blunt thoracic aortic injury p. 11 Tara Talaie, Jonathan J Morrison, James V O'Connor DOI:10.4103/jctt.jctt_7_18 Blu...
-
Publication date: Available online 19 June 2017 Source: Trends in Endocrinology & Metabolism Author(s): Ayelet Erez, Ilana Kolodkin-Ga...
-
MiR-153 regulates cardiomyocyte apoptosis by targeting Nrf2/HO-1 signaling Abstract MicroRNAs (miRNAs) play various roles in the regulation ...
-
Mitigating risk of aldosterone in diabetic kidney disease Purpose of review Diabetic kidney disease... Mitigating risk of aldosterone in dia...
-
EHCF+LGG reduces the incidence of other AMs in children with IgE-mediated CMA and increases the acquisition of tolerance at 12 months, 24 mo...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου